Women's Health

Research suggests that the COVID-19 pandemic has disrupted breast cancer screening, diagnosis and treatment.

A considerable proportion of women who never received an HPV vaccine also never underwent cervical cancer screening or were not up to date on screening in 2019, according to findings published in JAMA Network Open.

The FDA granted fast track designation to nemvaleukin alfa as part of combination therapy for treatment of platinum-resistant ovarian cancer, according to the agent’s manufacturer.

Vision impairment may increase risk for future depressive symptoms among women during midlife, according to study results published in Menopause: The Journal of The North American Menopause Society.

In a study published in the European Heart Journal, researchers found low maternal mortality among pregnant women with congenital heart disease in highly developed health care systems.

Among more than 2 million women in Sweden, preterm delivery yielded a significantly increased risk for future chronic hypertension, an association that persisted at least 40 years later, according to data published in JAMA Cardiology.

A comprehensive STEMI protocol led to reductions in sex disparities in guideline-directed medical therapy, door-to-balloon time, in-hospital mortality and ischemic in-hospital events, according to new data.

The American Heart Association issued a policy statement to address the rising rates of maternal mortality in the United States.

Establishing biennial mammography screening beginning at age 40 years could reduce breast cancer-associated mortality by 57% among Black women, according to study results published in Annals of Internal Medicine.

Healio’s editorial team is covering the latest research presented at the ASRM Scientific Congress & Expo in Baltimore, Oct. 17-20, with reports on key presentations, interviews with top experts and more.